
- Recently completed NODE-301 and ongoing NODE-301B studies can be used as two efficacy studies supporting a future NDA submission (target p-values of

- Recently completed NODE-301 and ongoing NODE-301B studies can be used as two efficacy studies supporting a future NDA submission (target p-values of
Milestone Pharmaceuticals Inc. on 6ix
Follow Milestone Pharmaceuticals into a list and get an email when it puts out news.
Follow Milestone Pharmaceuticals